| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K48334597 | CTRPv2 | pan-cancer | AAC | 0.099 | 0.2 |
| mRNA | gossypol | CTRPv2 | pan-cancer | AAC | -0.055 | 0.2 |
| mRNA | ABT-888 | CTRPv2 | pan-cancer | AAC | 0.054 | 0.2 |
| mRNA | JQ12 | GDSC1000 | pan-cancer | AAC | -0.053 | 0.2 |
| mRNA | Pyrimethamine | GDSC1000 | pan-cancer | AAC | -0.077 | 0.2 |
| mRNA | CCT007093 | GDSC1000 | pan-cancer | AAC | -0.052 | 0.2 |
| mRNA | Imatinib | GDSC1000 | pan-cancer | AAC | 0.079 | 0.2 |
| mRNA | Sorafenib | GDSC1000 | pan-cancer | AAC | -0.079 | 0.2 |
| mRNA | VAF-347 | CTRPv2 | pan-cancer | AAC | -0.07 | 0.2 |
| mRNA | tipifarnib | CTRPv2 | pan-cancer | AAC | 0.046 | 0.2 |